Login

Interview with Fernando Lehner, CEO of BVZ Group, on the Business | Fernando Lehner - CEO of bvz holding ag 00:10:00

Share On Facebook Share On Twitter

Fernando Lehner is the CEO of bvz holding ag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Securing Jalen Hurts' Financial Future: Key Advice for NFL Stars
00:10:00
AMMO, Inc Donates One Million Rounds to Ukrainian Armed Forces: A Message from CEO Fred Wagenhals | Fred Wagenhals, CEO, Ammo Inc.
00:10:00
When planning for a child with special needs under the Florida Retirement System, the Investment Plan offers more flexibility by allowing you to name a Special Needs Trust as a beneficiary, unlike the Pension Plan.|Robin Young, CFP®, RLP®, CeFT® is Presid
00:00:00
Stephanie Unwin, CEO, Phylogica Ltd
00:10:00
From Crowdfunding to the Stock Market: GenXone’s Roadmap to NewConnect | Michał Kaszuba, CEO, GenXone SA.
00:10:00
Financial Pulse: April 2024 Market Analysis with Michael McCarthy | Drew Tignanelli, Chairman, Financial Consulate Inc.
00:10:00
"Unlock the future of PetVivo Holdings, Inc. (NASDAQ) with Mr. John Lai, the driving force behind the company's vision, as he illuminates groundbreaking strategies and insights in this exclusive interview."|Mr. Lai has been a director and senior executive
00:10:00
Navigating the Cannabis Industry: Insights from Ron Throgmorton, CEO of Diego Pellicer
00:10:00
Clean Well Announces Share Buyback Program Amid Strong Financial Performance and Promising Pipeline Prospects | Dr Philippe Wolgen, CEO, Clinuvel Pharmaceuticals Ltd.
00:10:00
Strategic Insights on the Edelweiss Greater China Fund | Radhika Gupta - MD & CEO, Edelweiss Mutual Fund
00:10:00
Xciro Minerals and Williston Metals: Shastri Ramnath and Joshua Bailey Discuss Their Private Company's Vision
00:10:00
In an interview, Torsten Redlich, Global Head of Business Development for Division eHealth at secunet Security Networks AG, shares insights.

© 2017 - Neuhu+